TABLE OF CONTENTS
|  |  |  | Volume 37, Issue 2 (January 2012) |  | In this issue Commentaries Original Articles Erratum
Also new    AOP
| |  |  |  | Advertisement |  | Read a FREE issue of Neuropsychopharmacology today! Neuropsychopharmacology – the official journal of the American College of Neuropsychopharmacology – is dedicated to publishing highly-ranked research in psychiatry, neuroscience, pharmacology and pharmacy. To learn more and to read a FREE sample issue online, visit www.neuropsychopharmacology.org. | |  | | Commentaries | Top |  | The Many Faces of MeCP2Jacqueline F McGinty Neuropsychopharmacology 2011 37: 313-314; 10.1038/npp.2011.246 Full Text |  |  |  | Association of Mu-opioid and NMDA Receptors in the Periaqueductal Gray: What Does it Mean for Pain Control?Susan L Ingram Neuropsychopharmacology 2011 37: 315-316; 10.1038/npp.2011.241 Full Text |  |  |  | Expanding Our Understanding of Neurobiological Mechanisms of Resilience by Using Animal ModelsIsrael Liberzon and Dayan Knox Neuropsychopharmacology 2011 37: 317-318; 10.1038/npp.2011.259 Full Text |  |  |  | Gestational Methylazoxymethanol Acetate Administration Alters Proteomic and Metabolomic Markers of Hippocampal Glutamatergic TransmissionDaniel J Lodge and Anthony A Grace Neuropsychopharmacology 2011 37: 319-320; 10.1038/npp.2011.255 Full Text |  | Original Articles | Top |  | Differential Regulation of MeCP2 Phosphorylation in the CNS by Dopamine and SerotoninAshley N Hutchinson, Jie V Deng, Dipendra K Aryal, William C Wetsel and Anne E West Neuropsychopharmacology 2011 37: 321-337; advance online publication, September 28, 2011; 10.1038/npp.2011.190 Abstract | Full Text |  |  |  | The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain ControlMaría Rodríguez-Muñoz, Pilar Sánchez-Blázquez, Ana Vicente-Sánchez, Esther Berrocoso and Javier Garzón Neuropsychopharmacology 2011 37: 338-349; advance online publication, August 3, 2011; 10.1038/npp.2011.155 Abstract | Full Text |  |  |  | The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress DisorderHagit Cohen, Tianmin Liu, Nitsan Kozlovsky, Zeev Kaplan, Joseph Zohar and Aleksander A Mathé Neuropsychopharmacology 2011 37: 350-363; advance online publication, October 5, 2011; 10.1038/npp.2011.230 Abstract | Full Text |  |  |  | The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the HippocampusEva Hradetzky, Thomas M Sanderson, Tsz M Tsang, John L Sherwood, Stephen M Fitzjohn, Viktor Lakics, Nadia Malik, Stephanie Schoeffmann, Michael J O'Neill, Tammy MK Cheng, Laura W Harris, Hassan Rahmoune, Paul C Guest, Emanuele Sher, Graham L Collingridge, Elaine Holmes, Mark D Tricklebank and Sabine Bahn Neuropsychopharmacology 2011 37: 364-377; advance online publication, September 28, 2011; 10.1038/npp.2011.219 Abstract | Full Text |  |  |  | Activation of Nociceptin/Orphanin FQ Peptide Receptors Disrupts Visual but Not Auditory Sensorimotor Gating in BALB/cByJ Mice: Comparison to Dopamine Receptor AgonistsAurelia Ces, David Reiss, Ondine Walter, Jürgen Wichmann, Eric P Prinssen, Brigitte L Kieffer and Abdel-Mouttalib Ouagazzal Neuropsychopharmacology 2011 37: 378-389; advance online publication, August 31, 2011; 10.1038/npp.2011.175 Abstract | Full Text |  |  |  | Estradiol Modulates Effort-Based Decision Making in Female RatsKristina A Uban, Julia Rummel, Stan B Floresco and Liisa A M Galea Neuropsychopharmacology 2011 37: 390-401; advance online publication, August 31, 2011; 10.1038/npp.2011.176 Abstract | Full Text |  |  |  | The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use DisordersRaymond F Anton, Raye Z Litten, Daniel E Falk, Joseph M Palumbo, Raymond T Bartus, Rebecca L Robinson, Henry R Kranzler, Thomas R Kosten, Roger E Meyer, Charles P O'Brien, Karl Mann and Didier Meulien the ACTIVE Workgroup Neuropsychopharmacology 2011 37: 402-411; advance online publication, September 7, 2011; 10.1038/npp.2011.182 Abstract | Full Text |  |  |  | Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation ParadigmAndrés Uribe-Mariño, Audrey Francisco, Maria Angélica Castiblanco-Urbina, André Twardowschy, Carlos José Salgado-Rohner, José Alexandre S Crippa, Jaime Eduardo Cecílio Hallak, Antônio Waldo Zuardi and Norberto Cysne Coimbra Neuropsychopharmacology 2011 37: 412-421; advance online publication, September 14, 2011; 10.1038/npp.2011.188 Abstract | Full Text |  |  |  | GABAA Receptor Blockade Enhances Memory Consolidation by Increasing Hippocampal BDNF LevelsDong Hyun Kim, Jong Min Kim, Se Jin Park, Mudan Cai, Xiaotong Liu, Seungheon Lee, Chan Young Shin and Jong Hoon Ryu Neuropsychopharmacology 2011 37: 422-433; advance online publication, September 7, 2011; 10.1038/npp.2011.189 Abstract | Full Text |  |  |  | 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseLatha Devi and Masuo Ohno Neuropsychopharmacology 2011 37: 434-444; advance online publication, September 7, 2011; 10.1038/npp.2011.191 Abstract | Full Text |  |  |  | Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory StudyLara A Ray, Spencer Bujarski, Pauline F Chin and Karen Miotto Neuropsychopharmacology 2011 37: 445-455; advance online publication, September 7, 2011; 10.1038/npp.2011.192 Abstract | Full Text |  |  |  | Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense StressEti Ganon-Elazar and Irit Akirav Neuropsychopharmacology 2011 37: 456-466; advance online publication, September 14, 2011; 10.1038/npp.2011.204 Abstract | Full Text |  |  |  | Subjective and Neural Responses to Intravenous Alcohol in Young Adults with Light and Heavy Drinking PatternsJodi M Gilman, Vijay A Ramchandani, Tess Crouss and Daniel W Hommer Neuropsychopharmacology 2011 37: 467-477; advance online publication, September 28, 2011; 10.1038/npp.2011.206 Abstract | Full Text |  |  |  | Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in RatsPlínio C Casarotto, Ana Luisa B Terzian, Daniele C Aguiar, Hélio Zangrossi, Francisco S Guimarães, Carsten T Wotjak and Fabrício A Moreira Neuropsychopharmacology 2011 37: 478-486; advance online publication, September 21, 2011; 10.1038/npp.2011.207 Abstract | Full Text |  |  |  | Distinct Contributions of Dopamine in the Dorsolateral Striatum and Nucleus Accumbens Shell to the Reinforcing Properties of CocaineMaartje M J Veeneman, Mark H Broekhoven, Ruth Damsteegt and Louk J M J Vanderschuren Neuropsychopharmacology 2011 37: 487-498; advance online publication, September 14, 2011; 10.1038/npp.2011.209 Abstract | Full Text |  |  |  | Investigation of Anatomical Thalamo-Cortical Connectivity and fMRI Activation in SchizophreniaStefano Marenco, Jason L Stein, Antonina A Savostyanova, Fabio Sambataro, Hao-Yang Tan, Aaron L Goldman, Beth A Verchinski, Alan S Barnett, Dwight Dickinson, José A Apud, Joseph H Callicott, Andreas Meyer-Lindenberg and Daniel R Weinberger Neuropsychopharmacology 2011 37: 499-507; advance online publication, September 28, 2011; 10.1038/npp.2011.215 Abstract | Full Text |  |  |  | Dopamine Receptor Blockade Attenuates the General Incentive Motivational Effects of Noncontingently Delivered Rewards and Reward-Paired Cues Without Affecting Their Ability to Bias Action SelectionSean B Ostlund and Nigel T Maidment Neuropsychopharmacology 2011 37: 508-519; advance online publication, September 14, 2011; 10.1038/npp.2011.217 Abstract | Full Text |  |  |  | Corticotropin-Releasing Factor in the Norepinephrine Nucleus, Locus Coeruleus, Facilitates Behavioral FlexibilityKevin Snyder, Wei-Wen Wang, Rebecca Han, Kile McFadden and Rita J Valentino Neuropsychopharmacology 2011 37: 520-530; advance online publication, October 12, 2011; 10.1038/npp.2011.218 Abstract | Full Text |  |  |  | Growth Arrest and DNA-Damage-Inducible, Beta (GADD45b)-Mediated DNA Demethylation in Major PsychosisDavid P Gavin, Rajiv P Sharma, Kayla A Chase, Francesco Matrisciano, Erbo Dong and Alessandro Guidotti Neuropsychopharmacology 2011 37: 531-542; advance online publication, November 2, 2011; 10.1038/npp.2011.221 Abstract | Full Text |  |  |  | Reversal of Dopamine Inhibition of Dopaminergic Neurons of the Ventral Tegmental Area is Mediated by Protein Kinase CSudarat Nimitvilai, Devinder S Arora and Mark S Brodie Neuropsychopharmacology 2011 37: 543-556; advance online publication, October 5, 2011; 10.1038/npp.2011.222 Abstract | Full Text |  |  |  | Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1qLingjun Zuo, Joel Gelernter, Clarence K Zhang, Hongyu Zhao, Lingeng Lu, Henry R Kranzler, Robert T Malison, Chiang-Shan R Li, Fei Wang, Xiang-Yang Zhang, Hong-Wen Deng, John H Krystal, Fengyu Zhang and Xingguang Luo Neuropsychopharmacology 2011 37: 557-566; advance online publication, September 28, 2011; 10.1038/npp.2011.229 Abstract | Full Text |  |  |  | Early Life Stress Inhibits Expression of a Novel Innate Immune Pathway in the Developing HippocampusLan Wei, Arthur Simen, Shrikant Mane and Arie Kaffman Neuropsychopharmacology 2011 37: 567-580; advance online publication, October 12, 2011; 10.1038/npp.2011.239 Abstract | Full Text |  | Erratum | Top |  | Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1qLingjun Zuo, Joel Gelernter, Clarence K Zhang, Hongyu Zhao, Lingeng Lu, Henry R Kranzler, Robert T Malison, Chiang-Shan R Li, Fei Wang, Xiang-Yang Zhang, Hong-Wen Deng, John H Krystal, Fengyu Zhang and Xingguang Luo Neuropsychopharmacology 2012 37: 581-582; 10.1038/npp.2011.271 Full Text |  |  |  |  |  | Advertisement |  | Neuropsychopharmacology Reviews Highlighting Neurotherapeutics in 2012
Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles.
Visit www.neuropsychopharmacology.org and gain access to these articles before they are published in print. | |  | | Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | |
| |
No comments:
Post a Comment